| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 24,700 | 13 Dec 2024 | Direct | ||
| PALVELLA THERAPEUTICS, INC. | Director | Non-Qualified Stock Option (right to buy) | 12,350 | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | 10 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 20:00 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 1 | $0 | 4 | Director | 17 Dec 2024, 20:45 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 13 Dec 2024 | 0 | $0 | 3 | Director | 16 Dec 2024, 19:44 |